Author Archive: BIOtechNOW Editor

Welcome to Chicago, a City with Something for Everyone

Anna Protopapas

We are looking forward to welcoming you to Chicago for the 2013 BIO International Convention. Chicago is one of the world’s most vibrant and sophisticated cities and has a wealth of things to see and do. Here are some of the things I like to do when I’m in town. Our iconic sites If you only have time to do one thing while in town, I recommend a trip to Millennium Park, the city’s 25-acre Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Patent Utility Requirements for Biopharmaceutical Inventions: How Much is Enough?

Credit: Andrea Sivarsson

A debate between the innovative and generic perspectives on pharmaceutical patent law in Canada, moderated by David Kappos, will be held in Chicago on Monday April 22nd from 2:30-3:30pm in room S404A at this year’s BIO International Convention. Former Undersecretary of Commerce for Intellectual Property and USPTO Director David J. Kappos will moderate a panel of legal experts who will discuss recent developments in the area of patent utility and its implications for biopharmaceutical innovation.  Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , , , ,

Cranial Connections: Ontario’s Brain Research is Hardwired for Success

Moridi

Ontario has long been a leader in life sciences research and technology with brain exploration now taking centre-stage. Most recently, the provincial government committed $100 million to the Ontario Brain Institute, (OBI).  An independent nonprofit formed in 2010, the OBI  will help researchers and business leaders develop new treatments for neurological conditions ranging from Alzheimer’s and Parkinson’s to intractable epilepsy, cerebral palsy, autism and attention deficit and hyperactivity disorder. Headquartered in Toronto – a region that Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

The UK at BIO

The UK at BIO

There are more than 400 delegates from the UK attending the 2013 BIO International Convention. These include delegates from four innovative life science companies – Abcodia, Critical Pharmaceuticals, Nanomerics, and PsiOxus Therapeutics – who won the recent UK Trade and Investment (UKTI) Innovation Competition and will showcase their technologies to an international audience in Chicago. The UK presence at the convention will be centred on the UK pavilion (stand 4441) hosted by the BioIndustry Association (BIA) Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Evidence, Coverage, & Incentives: A PMC/BIO Solutions Summit Conference

Amy Miller Photo

Personalized medicine is changing the way medicine is practiced, and how drugs and biologics are developed. Systemic changes are needed to reflect this and support product development, but current economic, regulatory, and practice disincentives are impacting and slowing development. For example, medical advances often take years to be recognized in clinical care guidelines and cost containment policies often prevent new diagnostics from being priced at a level that supports innovation. The Personalized Medicine Coalition (PMC) and Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,